ライフサイエンスコーパス: abdominal surgery

1 s; 494 [40.9%] women; 681 [56.4%] undergoing abdominal surgery).

2 ith anaemia 10-42 days before elective major abdominal surgery.

3 m 17 overweight patients undergoing elective abdominal surgery.

4 rates of SBO after laparoscopic versus open abdominal surgery.

5 esidential status 6 months after nonelective abdominal surgery.

6 e most common causes for complications after abdominal surgery.

7 two cohorts of patients that underwent major abdominal surgery.

8 t frequent postoperative complications after abdominal surgery.

9 entation of glutamine dipeptide during major abdominal surgery.

10 is an important complication following major abdominal surgery.

11 s largely determines clinical recovery after abdominal surgery.

12 is higher after thoracic surgery than after abdominal surgery.

13 eratively for thromboprophylaxis after major abdominal surgery.

14 lective and clean or clean-contaminated open abdominal surgery.

15 ase, Clostridium difficile) undergoing major abdominal surgery.

16 is a frequent and common problem after major abdominal surgery.

17 e negative effect on the convalescence after abdominal surgery.

18 ce under conditions of stress, such as after abdominal surgery.

19 thered by direct observation during elective abdominal surgery.

20 postoperative mortality and morbidity after abdominal surgery.

21 to identify the risk factors for PPCs after abdominal surgery.

22 s on laparoscopic surgery compared with open abdominal surgery.

23 osis that causes small-bowel adhesions after abdominal surgery.

24 ersus conventional suture closure of midline abdominal surgery.

25 ction (SSI) rate in patients undergoing open abdominal surgery.

26 s of age) undergoing elective orthopaedic or abdominal surgery.

27 th standard care in patients undergoing open abdominal surgery.

28 ducing SSI rates in patients undergoing open abdominal surgery.

29 s anti-inflammatory but is effective only in abdominal surgery.

30 by physical disturbances to the bowel during abdominal surgery.

31 esolution of postoperative ileus after major abdominal surgery.

32 arly after major open and minimally invasive abdominal surgery.

33 removed when discovered incidentally during abdominal surgery.

34 Fibrous adhesions remain a major sequela of abdominal surgery.

35 e ileus in patients with cancer who have had abdominal surgery.

36 e a common cause of morbidity following open abdominal surgery.

37 to nonobese patients scheduled for elective abdominal surgery.

38 2 patients, most of whom had undergone major abdominal surgery.

39 perative infective complications in elective abdominal surgery.

40 pecimen obtained during previously scheduled abdominal surgery.

41 patients who had undergone major vascular or abdominal surgery.

42 l cells from 16 patients undergoing elective abdominal surgery.

43 Fifty-five patients had previous abdominal surgery.

44 tion when compared with other types of major abdominal surgery.

45 All study subjects were undergoing abdominal surgery.

46 compensated end-stage liver disease after an abdominal surgery.

47 struction, are common complications of intra-abdominal surgery.

48 ry complications who were scheduled for open abdominal surgery.

49 e not receiving statins at the time of intra-abdominal surgery.

50 plant surgery, joint arthroplasty, and major abdominal surgery.

51 reasons, and 47 (26.9%) underwent CD-related abdominal surgery.

52 ced risk of readmissions and ED visits after abdominal surgery.

53 y closed laparotomy incisions following open abdominal surgery.

54 tracorporeal membrane oxygenation, and other abdominal surgery.

55 tissues and reduce adhesion formation after abdominal surgery.

56 ntraoperative hypotension in dogs undergoing abdominal surgery.

57 ood transfusion in patients undergoing major abdominal surgery.

58 habilitation before elective (non-emergency) abdominal surgery.

59 ood transfusion in patients undergoing major abdominal surgery.

60 rgical site infections (SSIs) following open abdominal surgery.

61 been used to improve clinical outcomes after abdominal surgery.

62 e of morbidity and mortality following upper abdominal surgery.

63 alcohol in preventing SSIs after cardiac or abdominal surgery.

64 ing over time for laparoscopic compared with abdominal surgery.

65 e the consequence of uterine handling during abdominal surgery.

66 -operative anaemia in patients scheduled for abdominal surgery.

67 more frequently after thoracic surgery than abdominal surgery.

68 ospital length of stay after major emergency abdominal surgery.

69 re reduces surgical site infections (SSI) in abdominal surgery.

70 t common driver of long-term morbidity after abdominal surgery.

71 Thirty-four (23%) patients had previous abdominal surgery.

72 y of the ureters is a feared complication of abdominal surgery.

73 patients have an acceptable risk profile for abdominal surgery.

74 the optimal method of pain management after abdominal surgery.

75 ous psychiatric illness, substance abuse and abdominal surgery.

76 esions are a very common complication in the abdominal surgery.

77 longer than 8 hours, and recipient previous abdominal surgery.

78 re pathway for patients undergoing emergency abdominal surgery.

79 d catheters is an effective pain modality in abdominal surgery.

80 ars or older undergoing emergency open major abdominal surgery.

81 SIs remain a common cause of morbidity after abdominal surgery.

82 sed morbidity with liberal fluid regimens in abdominal surgery.

83 HSHs and LSHs for any advanced laparoscopic abdominal surgery.

84 ive care for older patients undergoing major abdominal surgery.

85 ngth of stay (LOS) among patients undergoing abdominal surgery.

86 ications of preoperative opioid use in major abdominal surgery.

87 elirium and LOS in older patients undergoing abdominal surgery.

88 event, particularly those who undergo major abdominal surgery.

89 op hypoxemic acute respiratory failure after abdominal surgery.

90 ffects observed in patients undergoing major abdominal surgery.

91 randomized controlled trials in general and abdominal surgery.

92 re assessed in 137 patients undergoing major abdominal surgery.

93 compounded postoperative complications after abdominal surgery.

94 ould include PEEP of 5-10 cmH2O during major abdominal surgery.

95 ere discharged to PAC facilities after major abdominal surgery.

96 ecystitis included advanced age and previous abdominal surgeries.

97 matory bowel disease without any prior intra-abdominal surgeries.

98 CD exacerbation-related hospitalizations or abdominal surgeries.

99 on perioperative outcomes after major upper abdominal surgeries.

100 48; 95% CI, 1.03-2.15) and IBD-related major abdominal surgery (1-year risk, 21.3% vs 8.0%; adjusted

101 the 13,292 patients with HAP following intra-abdominal surgery, 1421 died prior to discharge (mortali

102 than routine, use of nasogastric tubes after abdominal surgery (2 meta-analyses) and short-acting rat

103 130 cases per 40 565 procedures) to 0.7% for abdominal surgery (2198 cases per 335 034 procedures) to

104 0.2; 95% Confidence Interval (CI): 0.1-0.5), abdominal surgery (3.9% vs 17.5%, RR: 0.2, CI: 0.09-0.5)

105 0.2 [95% confidence interval {CI}, .1-.5]), abdominal surgery (3.9% vs 17.5%; RR, 0.2 [95% CI, .09-.

106 herapy (3.31 [2.22 to 4.92]), and undergoing abdominal surgery (4.82 [3.54 to 6.55]).

107 ocedures: 1) extubation; 2) tracheostomy; 3) abdominal surgery; 4) nonabdominal surgery; 5) magnetic

108 centage point increase in the probability of abdominal surgery (95% CI, 3.1-5.4 percentage points), a

109 so assessed whether the visceral stressor of abdominal surgery activated brain CRF neurons using doub

110 Abdominal surgery activates CRF-ir neurons selectively i

111 athways and biochemical coding through which abdominal surgery activates PVN neurons 1 h post surgery

112 Major abdominal surgery acutely upregulates innate-immune path

113 barrier developed to prevent adhesions after abdominal surgery, adheres well to wet tissue.

114 readmissions for long-term complications of abdominal surgery, adhesions are widely recognized as on

115 modulate IRI, as well as demonstrating that abdominal surgery alone leads to lymphocyte changes in k

116 onary comorbidities including multiple prior abdominal surgeries and a single functional left kidney.

117 Within the entire study population (major abdominal surgeries and craniotomies), we found an assoc

118 ons in a cohort of patients undergoing major abdominal surgeries and craniotomies, and (2) the effect

119 228/333 (68.4%) had a history of abdominal surgery and 85/333 (25.5%) underwent prior rad

120 nal interstitial edema often develops during abdominal surgery and after fluid resuscitation in traum

121 e units among 293 patients who had undergone abdominal surgery and developed hypoxemic respiratory fa

122 e obtained from 26 women undergoing elective abdominal surgery and gene expression examined in whole

123 atheter use, broad-spectrum antibiotics use, abdominal surgery and immune suppression.

124 When candidemia develops shortly after abdominal surgery and in patients with elevated AST, hig

125 gnature and SRSq scores in independent major abdominal surgery and polytrauma cohorts indicated good

126 ch as elderly people, individuals undergoing abdominal surgery and prostatic biopsy procedures, and p

127 aring placebo capsule two hours before major abdominal surgery and then twice daily until the first b

128 Primary outcome was SSI within 30 days after abdominal surgery and within 1 year after cardiac surger

129 e treated with antibiotics alone, 18.8% with abdominal surgery, and 32% with surgery and antimicrobia

130 years; 50 [66%] female); 40 (53%) underwent abdominal surgery, and 36 (47%) underwent breast surgery

131 Age, previous abdominal surgery, and chronic preoperative use of narco

132 esthesiology classification, male sex, prior abdominal surgery, and resection type.

133 s had higher body mass index, rates of prior abdominal surgery, and softer pancreatic remnants, where

134 adhesions represent a common complication of abdominal surgery, and tissue hypoxia is a main determin

135 carpal tunnel surgery, gynecologic surgery, abdominal surgery, and tonsillectomy, and were more like

136 cose management in patients undergoing major abdominal surgery anticipated to experience prolonged hy

137 Abdominal surgeries are lifesaving procedures but can be

138 Patients undergoing major abdominal surgery are at risk of life-threatening system

139 rgery, bowel resection, and aggressive upper abdominal surgery are commonly required to achieve optim

140 early 1 quarter of patients undergoing major abdominal surgery are depressed preoperatively.

141 Complications after abdominal surgery are often seen in emergency department

142 Weight <15 kg and previous abdominal surgery are risk factors for developing such c

143 ction (EHPVO), data on the morbimortality of abdominal surgery are scarce.

144 (INCPH), data on morbidity and mortality of abdominal surgery are scarce.

145 e mechanisms of action for specific types of abdominal surgery are still largely unknown and warrant

146 IH occurs after 10% to 15% of all abdominal surgeries (AS) and remains among the most chal

147 t-operative adhesions are a leading cause of abdominal surgery-associated morbidity.

148 postoperative kidney injury undergoing major abdominal surgery at 20 university hospitals in France f

149 e hospital visits before elective major open abdominal surgery at 46 UK tertiary care centres.

150 ospitals of patients with VADs who underwent abdominal surgeries between 2003 and 2015.

151 entify adult patients who underwent elective abdominal surgery between June 2009 and December 2012 (n

152 ar undergoing major thoracic (noncardiac) or abdominal surgery between March 2008 and July 2010, with

153 ndergoing liver resections, a model of major abdominal surgery, between September 2013 and September

154 aemoglobin concentration by 0.81 g/dl before abdominal surgery but does not reduce the need for peri-

155 is an alternative for epidural analgesia in abdominal surgery but studies have shown conflicting res

156 embrane reduces adhesions in gynecologic and abdominal surgery but this is the first trial in hepatec

157 tional electrosurgical tools particularly in abdominal surgery, but is yet to be validated with REIMS

158 litation may decrease complications in upper abdominal surgery, but not necessarily length of stay; r

159 protective against the occurrence of SSI in abdominal surgery, but these findings need to be confirm

160 protective against the occurrence of SSI in abdominal surgery, but these findings need to be confirm

161 Major abdominal surgery carries a high postoperative morbidity

162 l service, a substantial volume of emergency abdominal surgery cases, and contributed data to the Nat

163 Without specific treatment, major abdominal surgery causes a predictable gastrointestinal

164 Abdominal surgery causes postoperative gastrointestinal

165 Older patients undergoing abdominal surgery commonly experience preventable deliri

166 es and resource use in advanced laparoscopic abdominal surgery compared with low-star hospitals (LSHs

167 of adult patients undergoing elective major abdominal surgery comparing intraoperative GDFT versus c

168 ow-risk cases defined by absence of previous abdominal surgery, concomitant procedures, diabetes mell

169 justing for factors such as history of prior abdominal surgery, cul-de-sac obliteration, and addition

170 year (aOR 0.185, 95% CI 0.0950-0.360), intra-abdominal surgery during index hospitalization (aOR 0.21

171 etal outcomes in abdominal compared with non-abdominal surgery during pregnancy.

172 itals among 570 patients who were undergoing abdominal surgery, enrolled from February 2015 through O

173 doscopy such as hospitalization and previous abdominal surgery, erythromycin still resulted in an inc

174 IH is a prevalent complication after abdominal surgery, especially in high-risk groups.

175 r experience and is usually related to prior abdominal surgery, especially with creation of a Roux-en

176 y and nononcological patients, who underwent abdominal surgery for benign gynecological conditions an

177 Thromboembolic complications following major abdominal surgery for cancer may be reduced with the use

178 e of venous thromboembolism (VTE) after open abdominal surgery for cancer.

179 e among the most significant side-effects of abdominal surgery for cancer.

180 Patients undergoing abdominal surgery for CD at a tertiary referral center b

181 All patients undergoing abdominal surgery for CD in 2004 to 2016 by the senior a

182 tive use of narcotics in patients undergoing abdominal surgery for CD is associated with worse postop

183 scent surgical patients underwent additional abdominal surgery for complications of surgery or rapid

184 Independent predictors were previous abdominal surgery for IBD (OR, 2.7; 95% CI, 1-7.2; p = 0

185 new-onset ascites of unclear etiology after abdominal surgery for repair of an aortic aneurysm requi

186 formula (O-HN) in patients undergoing major abdominal surgery for upper gastrointestinal malignancie

187 he inclusion criteria are minimally invasive abdominal surgery formally analyzing the learning curve

188 without chronic liver disease, who underwent abdominal surgery from 2001 to 2017.

189 and omental fat samples were obtained during abdominal surgery from 38 women.

190 Individuals undergoing intra-abdominal surgery from January 1, 1996, to December 31,

191 alth record data from patients who underwent abdominal surgery from January 1, 2010, to December 31,

192 stry sponsorship in the field of general and abdominal surgery has not been evaluated.

193 Its impact on outcomes after major abdominal surgery has not been well characterized.

194 ts suffering from an incisional hernia after abdominal surgery have an impaired quality of life (QoL)

195 ed trials in patients undergoing major intra-abdominal surgery have challenged the historical use of

196 bin, biliary tree malignancy, previous upper abdominal surgery, hepatic encephalopathy, ascites, and

197 ety of Anesthesiologists grade III, previous abdominal surgery, histological diagnosis of colorectal

198 ondary outcomes included mortality, need for abdominal surgery, hospitalization duration, and cost.

199 y trial; 4403 patients undergoing cardiac or abdominal surgery in 3 tertiary care hospitals in Switze

200 tissue samples were obtained during emergent abdominal surgery in 4 patients with coronavirus disease

201 aged rats, we used laparotomy to mimic human abdominal surgery in adult (3 months) and aged (24 month

202 41, on Fos expression in the brain 1 h after abdominal surgery in conscious rats using immunocytochem

203 Abdominal surgery in naive rats induced Fos-ir in 30% of

204 ested to provide answers about the safety of abdominal surgery in patients with COVID-19.

205 Major emergency abdominal surgeries included laparotomy or laparoscopy d

206 underwent non-emergent, major orthopedic or abdominal surgery including hip/knee replacement, hepato

207 proportion of patients reported a history of abdominal surgery, including appendectomy (23%), cholecy

208 Postoperative adhesions are common after abdominal surgery, including appendectomy.

209 Patients who underwent advanced laparoscopic abdominal surgery, including bariatric surgery (sleeve g

210 ntensified therapy, abdominal radiation, and abdominal surgery increased the risk of certain GI compl

211 del showed that increased age, no history of abdominal surgery, increased visual analog scale pain sc

212 o 14% longer risk-adjusted pLOS for visceral abdominal surgery, independent of patient complexity and

213 tressin at reversing intracisternal CRF- and abdominal surgery-induced delay of gastric emptying in c

214 We previously reported that abdominal surgery induces Fos expression in specific hyp

215 Postoperative ileus (POI) develops after abdominal surgery irrespective of the site of surgery.

216 ith significant morbidity and mortality post abdominal surgery, irrespective of IC.

217 Major emergency abdominal surgery is associated with high morbidity and

218 Emergency abdominal surgery is associated with poor patient outcom

219 Prior abdominal surgery is not a contraindication.

220 linical outcomes in patients undergoing open abdominal surgery is uncertain.

221 In control groups (vehicle s.c. or i.c.v.), abdominal surgery (laparotomy with cecal manipulation) p

222 eus to resolve within a few days after major abdominal surgery-leads to significant medical consequen

223 roup of patients without HAP following intra-abdominal surgery (mortality = 1.2%) (P < 0.001).

224 Sex, age, tumor stage, previous abdominal surgery, neoadjuvant therapy, and surgical rad

225 urysm repair, nonresective thoracic surgery, abdominal surgery, neurosurgery, emergency surgery, gene

226 itoneal adhesion is a complication following abdominal surgery, observed in about 66% of cases.

227 y complications in patients undergoing major abdominal surgery (odds ratio 0.53, 95% confidence inter

228 matched pairs showed that a history of intra-abdominal surgery (odds ratio [OR] = 2.865; 95% confiden

229 ificant in patients undergoing orthopedic or abdominal surgery (odds ratio, 0.59; 95% CI, 0.35-0.99;

230 Of note, 53 patients had undergone previous abdominal surgery; of these, 26 patients required extens

231 examines the short- and long-term impact of abdominal surgery on the human brain immune system by po

232 score, diabetes, smoking, number of previous abdominal surgeries or hernia repairs, hernia defect siz

233 hundred thirty-four consecutive adults with abdominal surgery or acute pancreatitis and ICU stay 72

234 I (>28 kg/m2; OR 3.03 (1.75-5.30)), previous abdominal surgery (OR 2.48 (1.31-4.51)), patients outsid

235 ejunostomy (OR, 1.4), and a history of major abdominal surgery (OR, 1.4).

236 .4), blood loss >1 L (OR, 1.4), and previous abdominal surgery (OR, 1.7).

237 ng conditions, such as indwelling catheters, abdominal surgery, or antibiotic use.

238 70 years and older who underwent nonelective abdominal surgery over a 15-month period were prospectiv

239 only weight <15 kg (P = 0.003) and previous abdominal surgery (P = 0.008) were retained in the multi

240 iable regression models, history of previous abdominal surgery (P = 0.02) and body mass index (P = 0.

241 44) revealed male sex (P < 0.0001), previous abdominal surgery (P = 0.0200), a BMI greater than 30 (P

242 the time of transplant (P = 0.016), previous abdominal surgery (P = 0.047), and intraperitoneal surgi

243 tra-abdominal hypertension (multiple trauma, abdominal surgery, pancreatitis, post-cardiopulmonary re

244 of tegaserod suggested an increased risk of abdominal surgery, particularly cholecystectomy.

245 l value of probiotics in patients undergoing abdominal surgery, particularly colorectal surgery, rema

246 it to all elective patients undergoing major abdominal surgery, particularly those managed in an ERAS

247 ass index (BMI), gender, history of previous abdominal surgery (PAS), operative approach [laparoscopi

248 observational study, we included 5915 major abdominal surgery patients and 5063 craniotomy patients.

249 as significantly greater compared with intra-abdominal surgery patients who did not develop HAP (17.1

250 Cholecystectomy (XGB) is the most common abdominal surgery performed in the United States and is

251 edictive of death related to candidemia were abdominal surgery performed up to 1 week before candidem

252 epair, thoracic surgery, neurosurgery, upper abdominal surgery, peripheral vascular surgery, neck sur

253 all), major fungal infection, posttransplant abdominal surgery, posttransplant intensive care unit st

254 iables (age, gender, comorbidities, previous abdominal surgeries, presence of adenoma, and time betwe

255 d included age, cancer diagnosis, history of abdominal surgery, prior radiation therapy, evidence of

256 Major abdominal surgery-related stress and periprocedural inte

257 e risk of infectious complications following abdominal surgery [relative risk (RR) 0.56; 95% confiden

258 Adhesions between organs after abdominal surgery remain a significant unresolved clinic

259 ng 108 patients scheduled for elective intra-abdominal surgeries requiring a nasogastric tube (NGT) w

260 Morbidity of adhesiolysis during abdominal surgery seems an important health care problem

261 atory bowel disease, ascites, previous upper abdominal surgery, serum creatinine, and biliary tree ma

262 Further subgroup analysis of 67 intra-abdominal surgeries showed an in-hospital mortality of 2

263 relative risk, 1.26 [95% CI, 0.82-1.94]); in abdominal surgery, SSIs were present in 6.8% with povido

264 ative ileus (POI) is a common consequence of abdominal surgery that increases the risk of postoperati

265 In IBD patients undergoing abdominal surgery, the incidence of postural hypotension

266 n to prevent invasive candidiasis (IC) after abdominal surgery, the serum burden of BDG was determine

267 gin to prevent invasive candidosis (IC) post abdominal surgery, the serum burden of BDG was determine

268 is the most common indication for emergency abdominal surgery throughout the world and a common reas

269 risk of pulmonary complications after major abdominal surgery to either nonprotective mechanical ven

270 he data support that uterine handling during abdominal surgery under general anesthesia can impact ad

271 tive pulmonary complications undergoing open abdominal surgery under general anesthesia, intraoperati

272 tal outcomes following abdominal but not non-abdominal surgery under general anesthesia.

273 e, pretransplantation waiting time, previous abdominal surgery, United Network of Organ Sharing (UNOS

274 postoperative kidney injury undergoing major abdominal surgery, use of HES for volume replacement the

275 with hypoxemic respiratory failure following abdominal surgery, use of NIV compared with standard oxy

276 Among patients who underwent abdominal surgery, use of postoperative intravenous acet

277 ission rates among patients undergoing major abdominal surgery vary significantly.

278 risk and high-risk patients undergoing major abdominal surgery was associated with improved clinical

279 rioperative blood transfusions for oncologic abdominal surgery was observed.

280 l ACS-NSQIP and administrative databases for abdominal surgeries were matched then screened for iAEs

281 nded trial patients undergoing open elective abdominal surgery were assigned to either intraoperative

282 abdominal mass) or had previously undergone abdominal surgery were excluded.

283 Fifty patients undergoing open abdominal surgery were included, with 25 patients random

284 Adult patients undergoing thoracic or abdominal surgery were included.

285 study, 9 human patients undergoing elective abdominal surgery were treated postoperatively with a st

286 valuate adult patients undergoing major open abdominal surgery who received either 0.9% saline (30,99

287 For older patients undergoing abdominal surgery who received the mHELP, the odds of de

288 Among patients predominantly undergoing abdominal surgery who were at increased postoperative ri

289 consecutive cohort (n=150) undergoing major abdominal surgery, whole-blood RNA was collected preoper

290 or hip arthroplasty or laparoscopic-assisted abdominal surgery with an ASA physical status of 1-4 wer

291 ncidences of SSI in patients undergoing open abdominal surgery with and without pNPWT.

292 ncidences of SSI in patients undergoing open abdominal surgery with and without pNPWT.

293 cutive older patients scheduled for elective abdominal surgery with expected LOS longer than 6 days w

294 of patients aged 45 or over undergoing major abdominal surgery, with postoperative pneumonia associat

295 of prior AP episodes, prior cholelithiasis, abdominal surgery within 2 months, presence of epigastri

296 e optimal analgesic technique following open abdominal surgery within an enhanced recovery protocol r

297 ternative analgesic technique following open abdominal surgery within an enhanced recovery protocol w

298 the charts of patients with INCPH undergoing abdominal surgery within the Vascular Liver Disease Inte

299 as the control (sham) group was subjected to abdominal surgery without cecal ligation and perforation

300 anaemic patients before major open elective abdominal surgery would correct anaemia, reduce the need